BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CEACAM5, CEA
339 results:

  • 1. Limited prognostic role of routine serum markers (AP, cea, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery.
    Mehring G; Steinbach C; Pose R; Knipper S; Koehler D; Werner S; Riethdorf S; von Amsberg G; Ambrosini F; Maurer T
    World J Urol; 2024 Apr; 42(1):256. PubMed ID: 38656636
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]    [Full Text] [Related]  

  • 3. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
    Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
    BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
    van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH
    Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel exosome based therapeutic intervention against neuroendocrine prostate cancer.
    Saini S; Sreekumar A; Nathani S; Asante DM; Simmons MN
    Sci Rep; 2024 Feb; 14(1):2816. PubMed ID: 38307935
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Observation of Serological Index and Efficacy of Abiraterone Hydrochloride Tablets Combined with Endocrine Therapy in Patients with Metastatic Castration-Resistant prostate cancer.
    Yu L; Sun H; Che M; Gai W
    Arch Esp Urol; 2023 Oct; 76(8):588-595. PubMed ID: 37960958
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
    Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
    Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
    Ibnian AM; Khan OU; Chan R; Bangalore Lakshminarayana U; Kiran F; Abed S; Abbas R; Amir A; Al-Kofahi NK
    Am J Case Rep; 2023 Oct; 24():e941263. PubMed ID: 37793939
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
    Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
    Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine prostate cancer.
    Van Emmenis L; Ku SY; Gayvert K; Branch JR; Brady NJ; Basu S; Russell M; Cyrta J; Vosoughi A; Sailer V; Alnajar H; Dardenne E; Koumis E; Puca L; Robinson BD; Feldkamp MD; Winkis A; Majewski N; Rupnow B; Gottardis MM; Elemento O; Rubin MA; Beltran H; Rickman DS
    Cancer Res Commun; 2023 Aug; 3(8):1447-1459. PubMed ID: 37546702
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (cea) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
    Kiio LK; Onyatta JO; Ndangili PM; Oloo F; Santamaria C; Montuenga LM; Mbui DN
    Talanta; 2024 Jan; 266(Pt 1):124934. PubMed ID: 37454512
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis.
    Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C
    Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Electrochemical aptasensor based on the engineered core-shell MOF nanostructures for the detection of tumor antigens.
    Khan S; Cho WC; Sepahvand A; Haji Hosseinali S; Hussain A; Nejadi Babadaei MM; Sharifi M; Falahati M; Jaragh-Alhadad LA; Ten Hagen TLM; Li X
    J Nanobiotechnology; 2023 Apr; 21(1):136. PubMed ID: 37101280
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Robust Detection of cancer Markers in Human Serums Using All-Dielectric Metasurface Biosensors.
    Iwanaga M
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979589
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Economic evaluation of exercise interventions for individuals with cancer: A systematic review.
    Wang Y; McCarthy AL; Hayes SC; Gordon LG; Chiu V; Bailey TG; Stewart E; Tuffaha H
    Prev Med; 2023 Jul; 172():107491. PubMed ID: 36965520
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis.
    Jiao B; Basu A
    Pharmacoeconomics; 2023 Sep; 41(9):1065-1077. PubMed ID: 36877451
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical trials of self-replicating RNA-based cancer vaccines.
    Morse MA; Crosby EJ; Force J; Osada T; Hobeika AC; Hartman ZC; Berglund P; Smith J; Lyerly HK
    Cancer Gene Ther; 2023 Jun; 30(6):803-811. PubMed ID: 36765179
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Laser-assisted protein micropatterning in a thermoplastic device for multiplexed prostate cancer biomarker detection.
    Kling A; Dirscherl L; Dittrich PS
    Lab Chip; 2023 Jan; 23(3):534-541. PubMed ID: 36642981
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Recent Progress in Biosensors for Detection of Tumor Biomarkers.
    Li M; Jiang F; Xue L; Peng C; Shi Z; Zhang Z; Li J; Pan Y; Wang X; Feng C; Qiao D; Chen Z; Luo Q; Chen X
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364157
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.